2003
DOI: 10.3109/13506120308995250
|View full text |Cite
|
Sign up to set email alerts
|

An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians

Abstract: Serum amyloid A1 (SAA1), one of the two isotypes of acute phase SAA, is the predominant precursor to amyloid A (AA) protein, the chief constituent of fibrillar deposits in reactive (AA) amyloidosis. Prolonged hyperexpression of SAA protein accompanying chronic inflammation is critical to, but seems not to be sufficient for, the development of AA amyloidosis. Several previous studies have investigated the possibility of linkage between SAA1 exon 3 polymorphisms and susceptibility to amyloidosis. While the SAA1.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
40
0
1

Year Published

2005
2005
2024
2024

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 58 publications
(43 citation statements)
references
References 13 publications
2
40
0
1
Order By: Relevance
“…Interestingly, a polymorphism in the SAA1 promoter (Ϫ13 T/C) was subsequently found to be significantly related to AA amyloid risk in both populations and to be in linkage disequilibrium with SAA1.1 and SAA1.3 in Caucasians and Japanese, respectively, thus apparently explaining the previous discrepancy (27,28). However, this genetic association could not be further confirmed in a series of Finnish patients with RA (29) or in patients with FMF (18).…”
Section: Prevalence Of Aa Amyloidosis In Rheumatic Diseasesmentioning
confidence: 43%
“…Interestingly, a polymorphism in the SAA1 promoter (Ϫ13 T/C) was subsequently found to be significantly related to AA amyloid risk in both populations and to be in linkage disequilibrium with SAA1.1 and SAA1.3 in Caucasians and Japanese, respectively, thus apparently explaining the previous discrepancy (27,28). However, this genetic association could not be further confirmed in a series of Finnish patients with RA (29) or in patients with FMF (18).…”
Section: Prevalence Of Aa Amyloidosis In Rheumatic Diseasesmentioning
confidence: 43%
“…71,72 One analysis, rather than showing a significant increase in SAA 1.3, showed only a decrease in the 1.1 allele in the amyloid patients (P ¼ 0.002). 69 In that same study, the increase in SAA 1.3 was not quite significant (P ¼ 0.06), suggesting perhaps that the study did not have sufficient power. The difference between the RA patients with amyloidosis and the population controls without RA was statistically more impressive (P ¼ 0.01).…”
Section: Amyloidoses Derived From Molecules Involved In Immune Functionmentioning
confidence: 89%
“…In Caucasian groups, SAA 1.1 is much more common being significantly higher than in the Japanese controls. 68,69 In Japanese RA patients without a tissue diagnosis of amyloidosis, the allele distributions do not differ from controls without RA (Table 3). 70 However, in several studies of Japanese patients with RA and amyloid SAA 1.3 was significantly overrepresented, particularly in the homozygous state.…”
Section: Amyloidoses Derived From Molecules Involved In Immune Functionmentioning
confidence: 95%
See 2 more Smart Citations